Viyash Scientific Limited (NSE:VIYASH)
India · Delayed Price · Currency is INR 191.76
-1.17 (-0.61%)
Apr 2, 2026, 3:30 PM IST
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 83.73 billion as of April 2, 2026. Its market cap has increased by 134.15% in one year.
Market Cap
83.73B
Enterprise Value
88.70B
Revenue
18.17B
Ranking
n/a
PE Ratio
85.80
Stock Price
191.76
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 83.73B, an increase of 23,977.84%. That is a compound annual growth rate of 29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 83.73B | -7.68% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 184.55B |
| NATCO Pharma | 184.04B |
| Alembic Pharmaceuticals | 128.98B |
| Alivus Life Sciences | 121.46B |
| Cohance Lifesciences | 117.54B |
| Strides Pharma Science | 89.51B |
| Akums Drugs and Pharmaceuticals | 76.41B |
| Sudeep Pharma | 69.47B |